DEFB104A

defensin beta 104A, the group of Defensins, beta

Basic information

Region (hg38): 8:7836436-7841242

Previous symbols: [ "DEFB104" ]

Links

ENSG00000176782NCBI:140596HGNC:18115Uniprot:Q8WTQ1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DEFB104A gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DEFB104A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
6
clinvar
1
clinvar
7
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 6 0 1

Variants in DEFB104A

This is a list of pathogenic ClinVar variants found in the DEFB104A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-7836512-A-G Benign (Jun 26, 2017)768224
8-7836534-A-G not specified Uncertain significance (Jul 13, 2021)2236652
8-7841042-G-C not specified Uncertain significance (Aug 09, 2021)2365155
8-7841053-G-C not specified Uncertain significance (Jan 08, 2024)3081291
8-7841087-C-T not specified Uncertain significance (Mar 07, 2023)2458250
8-7841099-C-T not specified Uncertain significance (Aug 02, 2021)2240569
8-7841112-A-G not specified Uncertain significance (Jul 26, 2022)2387204
8-7841190-C-A not specified Likely benign (Nov 07, 2024)3500790

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DEFB104Aprotein_codingprotein_codingENST00000314265 24772
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.09370.589107039011070400.00000467
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2022831.20.8980.00000158422
Missense in Polyphen89.17440.87282
Synonymous0.735811.10.7195.61e-7123
Loss of Function0.043811.050.9544.46e-813

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001010.0000101
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103. {ECO:0000269|PubMed:11481241}.;
Pathway
Antimicrobial peptides;Innate Immune System;Immune System;Beta defensins;Defensins (Consensus)

Recessive Scores

pRec
0.132

Intolerance Scores

loftool
0.739
rvis_EVS
0.61
rvis_percentile_EVS
83

Haploinsufficiency Scores

pHI
0.150
hipred
N
hipred_score
0.238
ghis
0.414

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianLowLowLow
Primary ImmunodeficiencyLowLowLow
CancerLowLowLow

Gene ontology

Biological process
monocyte chemotaxis;innate immune response;defense response to Gram-negative bacterium;defense response to Gram-positive bacterium;positive chemotaxis;cellular response to phorbol 13-acetate 12-myristate
Cellular component
extracellular region
Molecular function
chemoattractant activity